IL33 and systemic lupus erythematosus: Treatment of pDCs with SLE IC NETs caused upregulation of p-IRF7, which was reversed following ST2L blockade (Figure 4C), therefore reiterating the role of the IL-33/ST2L axis in SLE NETs’ interferogenic effect.